Clinical Trials Browser

OTHER × Gliosarcoma × Nivolumab × Clear all

NCT02658981 2023-10-06

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT03014804 2020-07-24

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Phase 2 Withdrawn

Glioblastoma, Oligodendroglioma, Gliosarcoma